This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,609.63 firm fixed-price delivery order is for the supply of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product, with a completion date of December 13, 2024.
The award is not designated under any specific set-aside program. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is likely part of that broader IDC mechanism, enabling efficient government procurement of essential medical commodities for military personnel, veterans, and other federal beneficiaries.
Generated 3/13/25, 10:10 AM